Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

3.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K
Clinical Trials01:16

Clinical Trials

9.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.8K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

25
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
25
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

30
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
30
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.3K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

33
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
33

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of aneurysmorrhaphy with and without external support for the management of arteriovenous aneurysms.

The journal of vascular access·2025
Same author

Classifications of haemodialysis vascular access-induced limb ischaemia.

The journal of vascular access·2025
Same author

Classifications of haemodialysis vascular access stenosis: a scoping review.

BMJ open·2025
Same author

Validation of arteriovenous access stage (AVAS) classification: a prospective, international multicentre study.

Clinical kidney journal·2024
Same author

Evaluating the impact of an anti-microbial silver-impregnated surgical dressing on wound infections and healing: A randomised clinical trial.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society·2023
Same author

Identifying classification systems regarding vascular access for haemodialysis: protocol for a scoping review.

BMJ open·2022

Related Experiment Video

Updated: Oct 21, 2025

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

873

VAVASC study: Clinical trial protocol.

Lawrie Katerina1, O'Neill Stephen2, Waldauf Petr3

  • 1Division of Vascular Surgery, University Hospital Kralovske Vinohrady, Third Faculty of Medicine, Charles University, Prague, Czech Republic.

The Journal of Vascular Access
|September 2, 2021
PubMed
Summary
This summary is machine-generated.

The VAVASC study validates the Arterio Venous Access Stage Classification (AVAS) for upper limb vascular access. This international research aims to improve prediction and functionality of arteriovenous access in patients.

Keywords:
Arterio Venous Access Stage (AVAS)Validation of Arterio Venous Access Stage Classification (VAVASC)arteriovenous accessarteriovenous fistuladialysis

More Related Videos

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.5K
Author Spotlight: Exploring the Effects of Transauricular Vagus Nerve Stimulation
04:59

Author Spotlight: Exploring the Effects of Transauricular Vagus Nerve Stimulation

Published on: January 19, 2024

2.8K

Related Experiment Videos

Last Updated: Oct 21, 2025

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

873
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.5K
Author Spotlight: Exploring the Effects of Transauricular Vagus Nerve Stimulation
04:59

Author Spotlight: Exploring the Effects of Transauricular Vagus Nerve Stimulation

Published on: January 19, 2024

2.8K

Area of Science:

  • Vascular Surgery
  • Nephrology
  • Clinical Trials

Background:

  • The VAVASC study is a prospective, multicenter, international research initiative.
  • It focuses on validating the Arterio Venous Access Stage Classification (AVAS).
  • AVAS is a system for assessing vascular status in patients needing upper limb arteriovenous access.

Purpose of the Study:

  • To validate the AVAS classification system.
  • To assess the accuracy of predicting arteriovenous access creation.
  • To evaluate the functionality of created arteriovenous access.

Main Methods:

  • An observational, prospective, multicenter, international study design.
  • Data collection via an online platform including demographics, risk factors, and vascular mapping.
  • Statistical analysis using predictive models.

Main Results:

  • Currently, 140 patients from 4 countries are enrolled.
  • Participant recruitment and data collection are ongoing.
  • The study is evaluating AVAS class, predicted vs. actual access, and access functionality.

Conclusions:

  • The VAVASC study is actively recruiting participants and centers.
  • The findings will inform the clinical utility of the AVAS classification.
  • Collaboration is encouraged for broader validation.